(Updated) U.S. Legal Cannabis Pioneer Bright Green Corporation Appoints Industry Veteran Groovy Singh as New Chief Executive Officer

By adminJanuary 16, 2024Global News Feed

Singh’s appointment comes in support of the Company’s next evolution, which will be focused on investing in top talent, commencement of commercial operations, and investing in clinical research and development of plant based therapies, and expanding into cultivation and manufacturing of other scheduled substances.

Read the rest here:
(Updated) U.S. Legal Cannabis Pioneer Bright Green Corporation Appoints Industry Veteran Groovy Singh as New Chief Executive Officer

BioSenic reaches agreement on a binding term sheet with Phebra PTY Ltd. with respect to the development of the first oral formulation of arsenic…

By adminJanuary 16, 2024Global News Feed

PRESS RELEASE – INSIDE INFORMATION

Read the original:
BioSenic reaches agreement on a binding term sheet with Phebra PTY Ltd. with respect to the development of the first oral formulation of arsenic...

BioSenic S.A. : Transparency notifications received from François Rieger

By adminJanuary 16, 2024Global News Feed

PRESS RELEASE – REGULATED INFORMATION

See the original post here:
BioSenic S.A. : Transparency notifications received from François Rieger

Santhera Launches AGAMREE® (Vamorolone) in Germany as First Market for the Treatment of Duchenne Muscular Dystrophy

By adminJanuary 16, 2024Global News Feed

Pratteln, Switzerland, January 15, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces the launch of AGAMREE® (vamorolone) for the treatment of Duchenne muscular dystrophy (DMD) in patients 4 years of age and older, irrespective of the underlying mutation and ambulatory status, in Germany.

See more here:
Santhera Launches AGAMREE® (Vamorolone) in Germany as First Market for the Treatment of Duchenne Muscular Dystrophy

Sirona Biochem Launches Cosmetics Subsidiary- Sirona Laboratories™

By adminJanuary 16, 2024Global News Feed

VANCOUVER, Canada, Jan. 15, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is proud to introduce Sirona LaboratoriesTM - a wholly-owned subsidiary dedicated to maximizing the commercial potential of its breakthrough anti-aging skincare ingredient, GlycoProteMimTM.

View post:
Sirona Biochem Launches Cosmetics Subsidiary- Sirona Laboratories™

Basilea announces acquisition of preclinical antibiotics program from Spexis

By adminJanuary 16, 2024Global News Feed

Allschwil, Switzerland, January 15, 2024

The rest is here:
Basilea announces acquisition of preclinical antibiotics program from Spexis

ExeVir Bio Announces Positive Virus Neutralization Data for XVR012 Against Emerging COVID-19 Omicron Variants

By adminJanuary 16, 2024Global News Feed

Can provide protection for millions of immuno-compromised and elderly who are most vulnerable to COVID-19 Can provide protection for millions of immuno-compromised and elderly who are most vulnerable to COVID-19

Read the original post:
ExeVir Bio Announces Positive Virus Neutralization Data for XVR012 Against Emerging COVID-19 Omicron Variants

XORTX Announces $2 Million Public Offering

By adminJanuary 16, 2024Global News Feed

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES

Original post:
XORTX Announces $2 Million Public Offering

Guerbet: Financial agenda for 2024

By adminJanuary 16, 2024Global News Feed

Financial agenda for 2024

Originally posted here:
Guerbet: Financial agenda for 2024

AB Science receives notice of allowance for European patent covering masitinib until 2036 in the treatment of mastocytosis

By adminJanuary 16, 2024Global News Feed

PRESS RELEASE

Read the original here:
AB Science receives notice of allowance for European patent covering masitinib until 2036 in the treatment of mastocytosis